No Data
No Data
Fortress Biotech(FBIO.US) 10% Shareholder Buys US$17,589 in Common Stock
$Fortress Biotech(FBIO.US)$ 10% Shareholder ROSENWALD LINDSAY A MD purchased 10,000 shares of common stock on May 16, 2024 at an average price of $1.7589 for a total value of $17,589.Source: Announcem
Fortress Biotech(FBIO.US) Director Sells US$18,900 in Common Stock
$Fortress Biotech(FBIO.US)$ Director Klein Dov sold 10,000 shares of common stock on May 20, 2024 at an average price of $1.89 for a total value of $18,900.Source: Announcement What is statement of ch
Fortress Biotech Files for $50M Mixed Shelf
Roth MKM Reiterates Buy on Fortress Biotech, Maintains $10 Price Target
Roth MKM analyst Jason Wittes reiterates Fortress Biotech with a Buy and maintains $10 price target.
Fortress Biotech Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 471.46% Roth MKM $10 → $10 Reiterates Buy → Buy 03/19/2024 185.73% Alliance Global Partners → $
Fortress Biotech: A Strong Buy on Robust Financials and Strategic Advancements